2014: ASH First clinical results of P2 study of SGI-110 in intermediate or high risk MDS or CMML

25 November 2014/in 2014, Guadecitabine (SGI-110) – (Hematological Malignancies and Solid Tumors), Products

https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg 0 0 webadmin https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg webadmin2014-11-25 16:22:432016-11-25 16:23:132014: ASH First clinical results of P2 study of SGI-110 in intermediate or high risk MDS or CMML

Useful links

Home
Sitemap
Privacy Policy
Terms of Use
Legal

Member of the Otsuka Group

A selection of photos on this website
is courtesy of Valerio Berdini

2014: ASH First clinical results of P2 study of SGI-110 in intermediate or high...2015 ASCPT: Systems Pharmacology Modeling of Decitabine and SGI-110

Scroll to top

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok